Table 2 Laboratory results at baseline and during follow up visits
Visit 1 | Visit 2 | Visit 3 | |
|---|---|---|---|
Median (IQR) | Median (IQR) | Median (IQR) | |
FXIIIa (%) | 96.5 (77.7–115.0) | 100.0 (85.0–113.5) | 101 (86.5–121.5) |
WBC (Gpt/L) | 7.6 (5.9–9.5) | 8.1 (6.5–11.1) | 7.3 (5.9–9.2) |
Hb (mmol/L) | 8.4 (7.8–9.1) | 8.4 (7.5–8.6) | 8.1 (7.7–8.8) |
PLT (Gpt/L) | 307 (248–395) | 312 (288–382) | 302 (260–366) |
Ferritin (ng/mL) | 46.3 (21.9–146.0) | 32.6 (11.9–55.6) | 34 (14.7–93.8) |
Transf. sat. (%) | 17.7 (9.3–21.0) | 17.9 (9.6–25.8) | 19.4 (13.1–29.6) |
CRP (mg/L) | 13.1 (5.6–15.7) | 4.4 (1.7–14.8) | 1.3 (0.8–7.5) |
Calprotectin (µg/g) | 374.0 (98.0–1967.0) | 272 (81.9–1336.2) | 211 (65.5–522.5) |
Thrombin Time (s) | 14.6 (13.9–15.5) | 14.8 (13.9–15.6) | 14.9 (14.5–16.0) |
Antithrombin (%) | 104.0 (94.0–110.0) | 98.0 (92.5–113.0) | 101.0 (91.5–107.0) |
Fibrinogen (g/L) | 3.7 (2.9–4.4) | 3.5 (2.4–3.9) | 3.5 (2.4–4.0) |
D–Dimer (µg/L) | 199.0 (94.2–377.0) | 164.0 (92.0–408.5) | 129.0 (86.0–252.0) |